首页|参麦注射液联合消心痛注射液治疗冠心病心绞痛临床分析

参麦注射液联合消心痛注射液治疗冠心病心绞痛临床分析

扫码查看
目的:探讨参麦注射液联合消心痛注射液治疗冠心病心绞痛的临床疗效。方法:回顾性分析我院68例冠心病心绞痛患者临床资料,随机分为治疗组和对照组各34例,治疗组采用参麦注射液,同时合用消心痛注射液;对照组采用复方丹参注射液、硝酸甘油加入5%葡萄糖中静点,观察两组心电图变化及心绞痛的疗效。结果:治疗组治疗心绞痛疗效的总有效率97.1%,明显优于B组70.6%(P<0.05),心电图的改善率治疗组与对照组差异显著(P<0.05)。结论:参麦注射液联合消心痛注射液治疗冠心病心绞痛临床疗效显著,值得临床推广应用。
Shenmai injection combined with clinical analysis of isosorbide dinitrate injection in the treatment of angina pectoris of coronary heart disease isosorbide
To explore the clinical therapeutic effect of Shenmai injection combined with Isosorbide Mononitrate Injection treating coronary heart disease and angina pectoris.Methods:a retrospective analysis of our hospital 68 cases of angina pectoris of coronary heart disease in patients with clinical data, were randomly divided into the treatment group and the control group with 34 cases in each group, the treatment group was treated with Shenmai injection, and combination of isosorbide dinitrate injection; the control group were treated with Danshen Injection, adding 5% glucose intravenous nitroglycerin, observation of curative effect of two groups of ECG changes and angina pectoris the.Resultsthe curative effect in treating angina pectoris treatment group total effective rate was 97.1%, significantly higher than in group B 70.6% (P&amp;lt; 0.05), ECG improvement rate of the treatment group and the control group had significant difference (P&amp;lt; 0.05).ConclusionShenmai injection combined with Isosorbide Mononitrate Injection treating coronary heart disease and angina pectoris clinical effect is significant, worthy of clinical application.

anginaShenmai injectionisosorbide dinitrate

陈智勇

展开 >

四川省仁寿县中医医院 四川 仁寿 620500

心绞痛 参麦注射液 消心痛注射液

2014

中国保健营养(中旬刊)
全国卫生产业企业管理协会

中国保健营养(中旬刊)

ISSN:1004-7484
年,卷(期):2014.(7)
  • 1
  • 4